Summary by Moomoo AI
Vertex Pharmaceuticals Inc. officer and director, Kewalramani Reshma, is set to sell 1,565 shares of common stock on 05/24/2024, according to a recent filing. The shares, valued at an aggregate market value of $715,205, were originally acquired on the same date through an option granted on 02/06/2019. The transaction will be executed with cash payment. This planned sale follows a significant transaction in the past three months where a total of 15,202 shares were sold, amounting to gross proceeds of $6,795,294.